1.
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.
Ann Hepatol
; : 101185, 2023 Dec 01.
Article
in English
| MEDLINE
| ID: mdl-38042481
ABSTRACT
The most common primary liver tumors are hepatocellular carcinoma and cholangiocarcinoma. They constitute the sixth most common neoplasia and the third cause of cancer-related deaths worldwide. Although both tumors may share etiologic factors, diagnosis, prognostic factors, and treatments, they differ substantially in determining distinctive clinical management. In recent years, significant advances have been made in the management of these neoplasms, particularly in advanced stages. In this review, we focus on the most relevant diagnostic, prognostic, and treatment aspects of both, hepatocellular carcinoma and cholangiocarcinoma, underlying their applicability in Latin America.
2.
Liver Int
; 42(2): 268-270, 2022 02.
Article
in English
| MEDLINE
| ID: mdl-35092336
3.
Aliment Pharmacol Ther
; 54(6): 850-851, 2021 09.
Article
in English
| MEDLINE
| ID: mdl-34425013
Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Aspirin/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Carcinoma, Hepatocellular/epidemiology , Carcinoma, Hepatocellular/prevention & control , Chemoprevention , Humans , Liver Neoplasms/drug therapy , Liver Neoplasms/epidemiology , Liver Neoplasms/prevention & control
4.
Liver Int
; 40(8): 1829-1831, 2020 08.
Article
in English
| MEDLINE
| ID: mdl-33135859
Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Algorithms , Humans , Liver Neoplasms/drug therapy
5.
Liver Int
; 40(4): 751-753, 2020 04.
Article
in English
| MEDLINE
| ID: mdl-32255572